nodes	percent_of_prediction	percent_of_DWPC	metapath
Temozolomide—Condition aggravated—Riluzole—amyotrophic lateral sclerosis	0.0517	0.0517	CcSEcCtD
Temozolomide—Hemiplegia—Riluzole—amyotrophic lateral sclerosis	0.0265	0.0265	CcSEcCtD
Temozolomide—Hyperacusis—Riluzole—amyotrophic lateral sclerosis	0.0254	0.0254	CcSEcCtD
Temozolomide—Traumatic liver injury—Riluzole—amyotrophic lateral sclerosis	0.0254	0.0254	CcSEcCtD
Temozolomide—Cerebral ischaemia—Riluzole—amyotrophic lateral sclerosis	0.0195	0.0195	CcSEcCtD
Temozolomide—Tongue discolouration—Riluzole—amyotrophic lateral sclerosis	0.0195	0.0195	CcSEcCtD
Temozolomide—Faecal incontinence—Riluzole—amyotrophic lateral sclerosis	0.0187	0.0187	CcSEcCtD
Temozolomide—Lymphopenia—Riluzole—amyotrophic lateral sclerosis	0.0185	0.0185	CcSEcCtD
Temozolomide—Cerebral haemorrhage—Riluzole—amyotrophic lateral sclerosis	0.0171	0.0171	CcSEcCtD
Temozolomide—Oral candidiasis—Riluzole—amyotrophic lateral sclerosis	0.0149	0.0149	CcSEcCtD
Temozolomide—Embolism—Riluzole—amyotrophic lateral sclerosis	0.0147	0.0147	CcSEcCtD
Temozolomide—Tooth disorder—Riluzole—amyotrophic lateral sclerosis	0.0146	0.0146	CcSEcCtD
Temozolomide—Interstitial lung disease—Riluzole—amyotrophic lateral sclerosis	0.0133	0.0133	CcSEcCtD
Temozolomide—Lung disorder—Riluzole—amyotrophic lateral sclerosis	0.0133	0.0133	CcSEcCtD
Temozolomide—Apathy—Riluzole—amyotrophic lateral sclerosis	0.0132	0.0132	CcSEcCtD
Temozolomide—Flat affect—Riluzole—amyotrophic lateral sclerosis	0.0131	0.0131	CcSEcCtD
Temozolomide—Extrapyramidal disorder—Riluzole—amyotrophic lateral sclerosis	0.0125	0.0125	CcSEcCtD
Temozolomide—Gamma-glutamyltransferase increased—Riluzole—amyotrophic lateral sclerosis	0.0115	0.0115	CcSEcCtD
Temozolomide—Petechiae—Riluzole—amyotrophic lateral sclerosis	0.0115	0.0115	CcSEcCtD
Temozolomide—Endocrine disorder—Riluzole—amyotrophic lateral sclerosis	0.0114	0.0114	CcSEcCtD
Temozolomide—Liver injury—Riluzole—amyotrophic lateral sclerosis	0.0112	0.0112	CcSEcCtD
Temozolomide—Breast pain—Riluzole—amyotrophic lateral sclerosis	0.0108	0.0108	CcSEcCtD
Temozolomide—Amenorrhoea—Riluzole—amyotrophic lateral sclerosis	0.0108	0.0108	CcSEcCtD
Temozolomide—Gait disturbance—Riluzole—amyotrophic lateral sclerosis	0.00968	0.00968	CcSEcCtD
Temozolomide—Respiratory failure—Riluzole—amyotrophic lateral sclerosis	0.00962	0.00962	CcSEcCtD
Temozolomide—Coordination abnormal—Riluzole—amyotrophic lateral sclerosis	0.00962	0.00962	CcSEcCtD
Temozolomide—Phosphatase alkaline increased—Riluzole—amyotrophic lateral sclerosis	0.00945	0.00945	CcSEcCtD
Temozolomide—Pulmonary embolism—Riluzole—amyotrophic lateral sclerosis	0.00945	0.00945	CcSEcCtD
Temozolomide—Depressed level of consciousness—Riluzole—amyotrophic lateral sclerosis	0.00912	0.00912	CcSEcCtD
Temozolomide—Urinary incontinence—Riluzole—amyotrophic lateral sclerosis	0.00912	0.00912	CcSEcCtD
Temozolomide—Candida infection—Riluzole—amyotrophic lateral sclerosis	0.00902	0.00902	CcSEcCtD
Temozolomide—Aplastic anaemia—Riluzole—amyotrophic lateral sclerosis	0.00887	0.00887	CcSEcCtD
Temozolomide—Neoplasm—Riluzole—amyotrophic lateral sclerosis	0.00854	0.00854	CcSEcCtD
Temozolomide—Mental disability—Riluzole—amyotrophic lateral sclerosis	0.0082	0.0082	CcSEcCtD
Temozolomide—Ear pain—Riluzole—amyotrophic lateral sclerosis	0.00804	0.00804	CcSEcCtD
Temozolomide—Blood alkaline phosphatase increased—Riluzole—amyotrophic lateral sclerosis	0.00788	0.00788	CcSEcCtD
Temozolomide—Deafness—Riluzole—amyotrophic lateral sclerosis	0.00767	0.00767	CcSEcCtD
Temozolomide—Vascular purpura—Riluzole—amyotrophic lateral sclerosis	0.00767	0.00767	CcSEcCtD
Temozolomide—Amnesia—Riluzole—amyotrophic lateral sclerosis	0.0073	0.0073	CcSEcCtD
Temozolomide—Dermatitis exfoliative—Riluzole—amyotrophic lateral sclerosis	0.00727	0.00727	CcSEcCtD
Temozolomide—Thirst—Riluzole—amyotrophic lateral sclerosis	0.00721	0.00721	CcSEcCtD
Temozolomide—Purpura—Riluzole—amyotrophic lateral sclerosis	0.00712	0.00712	CcSEcCtD
Temozolomide—Diplopia—Riluzole—amyotrophic lateral sclerosis	0.00686	0.00686	CcSEcCtD
Temozolomide—Affect lability—Riluzole—amyotrophic lateral sclerosis	0.00675	0.00675	CcSEcCtD
Temozolomide—Face oedema—Riluzole—amyotrophic lateral sclerosis	0.00662	0.00662	CcSEcCtD
Temozolomide—Mood swings—Riluzole—amyotrophic lateral sclerosis	0.0065	0.0065	CcSEcCtD
Temozolomide—Ataxia—Riluzole—amyotrophic lateral sclerosis	0.00645	0.00645	CcSEcCtD
Temozolomide—Dehydration—Riluzole—amyotrophic lateral sclerosis	0.00638	0.00638	CcSEcCtD
Temozolomide—Hypokalaemia—Riluzole—amyotrophic lateral sclerosis	0.00624	0.00624	CcSEcCtD
Temozolomide—Breast disorder—Riluzole—amyotrophic lateral sclerosis	0.0062	0.0062	CcSEcCtD
Temozolomide—Aspartate aminotransferase increased—Riluzole—amyotrophic lateral sclerosis	0.00618	0.00618	CcSEcCtD
Temozolomide—Muscular weakness—Riluzole—amyotrophic lateral sclerosis	0.00605	0.00605	CcSEcCtD
Temozolomide—Alanine aminotransferase increased—Riluzole—amyotrophic lateral sclerosis	0.00605	0.00605	CcSEcCtD
Temozolomide—Abdominal distension—Riluzole—amyotrophic lateral sclerosis	0.00597	0.00597	CcSEcCtD
Temozolomide—Dysphagia—Riluzole—amyotrophic lateral sclerosis	0.00593	0.00593	CcSEcCtD
Temozolomide—Bronchitis—Riluzole—amyotrophic lateral sclerosis	0.0057	0.0057	CcSEcCtD
Temozolomide—Pancytopenia—Riluzole—amyotrophic lateral sclerosis	0.00563	0.00563	CcSEcCtD
Temozolomide—Dysuria—Riluzole—amyotrophic lateral sclerosis	0.00554	0.00554	CcSEcCtD
Temozolomide—Neutropenia—Riluzole—amyotrophic lateral sclerosis	0.00554	0.00554	CcSEcCtD
Temozolomide—Pollakiuria—Riluzole—amyotrophic lateral sclerosis	0.00548	0.00548	CcSEcCtD
Temozolomide—Erectile dysfunction—Riluzole—amyotrophic lateral sclerosis	0.00546	0.00546	CcSEcCtD
Temozolomide—Photosensitivity reaction—Riluzole—amyotrophic lateral sclerosis	0.00541	0.00541	CcSEcCtD
Temozolomide—Weight increased—Riluzole—amyotrophic lateral sclerosis	0.00539	0.00539	CcSEcCtD
Temozolomide—Weight decreased—Riluzole—amyotrophic lateral sclerosis	0.00536	0.00536	CcSEcCtD
Temozolomide—Pneumonia—Riluzole—amyotrophic lateral sclerosis	0.00532	0.00532	CcSEcCtD
Temozolomide—Infestation NOS—Riluzole—amyotrophic lateral sclerosis	0.00528	0.00528	CcSEcCtD
Temozolomide—Infestation—Riluzole—amyotrophic lateral sclerosis	0.00528	0.00528	CcSEcCtD
Temozolomide—Depression—Riluzole—amyotrophic lateral sclerosis	0.00527	0.00527	CcSEcCtD
Temozolomide—Neuropathy peripheral—Riluzole—amyotrophic lateral sclerosis	0.00518	0.00518	CcSEcCtD
Temozolomide—Stomatitis—Riluzole—amyotrophic lateral sclerosis	0.00515	0.00515	CcSEcCtD
Temozolomide—Urinary tract infection—Riluzole—amyotrophic lateral sclerosis	0.00514	0.00514	CcSEcCtD
Temozolomide—Hepatobiliary disease—Riluzole—amyotrophic lateral sclerosis	0.005	0.005	CcSEcCtD
Temozolomide—Sinusitis—Riluzole—amyotrophic lateral sclerosis	0.00496	0.00496	CcSEcCtD
Temozolomide—Haemoglobin—Riluzole—amyotrophic lateral sclerosis	0.00477	0.00477	CcSEcCtD
Temozolomide—Hepatitis—Riluzole—amyotrophic lateral sclerosis	0.00474	0.00474	CcSEcCtD
Temozolomide—Haemorrhage—Riluzole—amyotrophic lateral sclerosis	0.00474	0.00474	CcSEcCtD
Temozolomide—Hypoaesthesia—Riluzole—amyotrophic lateral sclerosis	0.00472	0.00472	CcSEcCtD
Temozolomide—Hallucination—Riluzole—amyotrophic lateral sclerosis	0.00472	0.00472	CcSEcCtD
Temozolomide—Pharyngitis—Riluzole—amyotrophic lateral sclerosis	0.00471	0.00471	CcSEcCtD
Temozolomide—Urinary tract disorder—Riluzole—amyotrophic lateral sclerosis	0.00469	0.00469	CcSEcCtD
Temozolomide—Oedema peripheral—Riluzole—amyotrophic lateral sclerosis	0.00467	0.00467	CcSEcCtD
Temozolomide—Connective tissue disorder—Riluzole—amyotrophic lateral sclerosis	0.00466	0.00466	CcSEcCtD
Temozolomide—Urethral disorder—Riluzole—amyotrophic lateral sclerosis	0.00465	0.00465	CcSEcCtD
Temozolomide—Erythema multiforme—Riluzole—amyotrophic lateral sclerosis	0.00449	0.00449	CcSEcCtD
Temozolomide—Eye disorder—Riluzole—amyotrophic lateral sclerosis	0.00443	0.00443	CcSEcCtD
Temozolomide—Cardiac disorder—Riluzole—amyotrophic lateral sclerosis	0.0044	0.0044	CcSEcCtD
Temozolomide—Angiopathy—Riluzole—amyotrophic lateral sclerosis	0.0043	0.0043	CcSEcCtD
Temozolomide—Immune system disorder—Riluzole—amyotrophic lateral sclerosis	0.00429	0.00429	CcSEcCtD
Temozolomide—Mediastinal disorder—Riluzole—amyotrophic lateral sclerosis	0.00428	0.00428	CcSEcCtD
Temozolomide—Chills—Riluzole—amyotrophic lateral sclerosis	0.00426	0.00426	CcSEcCtD
Temozolomide—Alopecia—Riluzole—amyotrophic lateral sclerosis	0.00419	0.00419	CcSEcCtD
Temozolomide—Mental disorder—Riluzole—amyotrophic lateral sclerosis	0.00416	0.00416	CcSEcCtD
Temozolomide—Malnutrition—Riluzole—amyotrophic lateral sclerosis	0.00413	0.00413	CcSEcCtD
Temozolomide—Dysgeusia—Riluzole—amyotrophic lateral sclerosis	0.00404	0.00404	CcSEcCtD
Temozolomide—Back pain—Riluzole—amyotrophic lateral sclerosis	0.00399	0.00399	CcSEcCtD
Temozolomide—Tremor—Riluzole—amyotrophic lateral sclerosis	0.00387	0.00387	CcSEcCtD
Temozolomide—Ill-defined disorder—Riluzole—amyotrophic lateral sclerosis	0.00383	0.00383	CcSEcCtD
Temozolomide—Anaemia—Riluzole—amyotrophic lateral sclerosis	0.00382	0.00382	CcSEcCtD
Temozolomide—Agitation—Riluzole—amyotrophic lateral sclerosis	0.0038	0.0038	CcSEcCtD
Temozolomide—Angioedema—Riluzole—amyotrophic lateral sclerosis	0.00377	0.00377	CcSEcCtD
Temozolomide—Malaise—Riluzole—amyotrophic lateral sclerosis	0.00372	0.00372	CcSEcCtD
Temozolomide—Vertigo—Riluzole—amyotrophic lateral sclerosis	0.00371	0.00371	CcSEcCtD
Temozolomide—Leukopenia—Riluzole—amyotrophic lateral sclerosis	0.0037	0.0037	CcSEcCtD
Temozolomide—Palpitations—Riluzole—amyotrophic lateral sclerosis	0.00365	0.00365	CcSEcCtD
Temozolomide—Cough—Riluzole—amyotrophic lateral sclerosis	0.0036	0.0036	CcSEcCtD
Temozolomide—Convulsion—Riluzole—amyotrophic lateral sclerosis	0.00358	0.00358	CcSEcCtD
Temozolomide—Hypertension—Riluzole—amyotrophic lateral sclerosis	0.00357	0.00357	CcSEcCtD
Temozolomide—Arthralgia—Riluzole—amyotrophic lateral sclerosis	0.00352	0.00352	CcSEcCtD
Temozolomide—Myalgia—Riluzole—amyotrophic lateral sclerosis	0.00352	0.00352	CcSEcCtD
Temozolomide—Anxiety—Riluzole—amyotrophic lateral sclerosis	0.0035	0.0035	CcSEcCtD
Temozolomide—Unspecified disorder of skin and subcutaneous tissue—Riluzole—amyotrophic lateral sclerosis	0.00349	0.00349	CcSEcCtD
Temozolomide—Discomfort—Riluzole—amyotrophic lateral sclerosis	0.00347	0.00347	CcSEcCtD
Temozolomide—Dry mouth—Riluzole—amyotrophic lateral sclerosis	0.00344	0.00344	CcSEcCtD
Temozolomide—Confusional state—Riluzole—amyotrophic lateral sclerosis	0.0034	0.0034	CcSEcCtD
Temozolomide—Oedema—Riluzole—amyotrophic lateral sclerosis	0.00337	0.00337	CcSEcCtD
Temozolomide—Anaphylactic shock—Riluzole—amyotrophic lateral sclerosis	0.00337	0.00337	CcSEcCtD
Temozolomide—Infection—Riluzole—amyotrophic lateral sclerosis	0.00335	0.00335	CcSEcCtD
Temozolomide—Nervous system disorder—Riluzole—amyotrophic lateral sclerosis	0.00331	0.00331	CcSEcCtD
Temozolomide—Thrombocytopenia—Riluzole—amyotrophic lateral sclerosis	0.0033	0.0033	CcSEcCtD
Temozolomide—Skin disorder—Riluzole—amyotrophic lateral sclerosis	0.00327	0.00327	CcSEcCtD
Temozolomide—Hyperhidrosis—Riluzole—amyotrophic lateral sclerosis	0.00326	0.00326	CcSEcCtD
Temozolomide—Anorexia—Riluzole—amyotrophic lateral sclerosis	0.00321	0.00321	CcSEcCtD
Temozolomide—Musculoskeletal discomfort—Riluzole—amyotrophic lateral sclerosis	0.00307	0.00307	CcSEcCtD
Temozolomide—Insomnia—Riluzole—amyotrophic lateral sclerosis	0.00305	0.00305	CcSEcCtD
Temozolomide—Paraesthesia—Riluzole—amyotrophic lateral sclerosis	0.00303	0.00303	CcSEcCtD
Temozolomide—Dyspnoea—Riluzole—amyotrophic lateral sclerosis	0.003	0.003	CcSEcCtD
Temozolomide—Somnolence—Riluzole—amyotrophic lateral sclerosis	0.003	0.003	CcSEcCtD
Temozolomide—Dyspepsia—Riluzole—amyotrophic lateral sclerosis	0.00297	0.00297	CcSEcCtD
Temozolomide—Decreased appetite—Riluzole—amyotrophic lateral sclerosis	0.00293	0.00293	CcSEcCtD
Temozolomide—Gastrointestinal disorder—Riluzole—amyotrophic lateral sclerosis	0.00291	0.00291	CcSEcCtD
Temozolomide—Fatigue—Riluzole—amyotrophic lateral sclerosis	0.00291	0.00291	CcSEcCtD
Temozolomide—Constipation—Riluzole—amyotrophic lateral sclerosis	0.00288	0.00288	CcSEcCtD
Temozolomide—Pain—Riluzole—amyotrophic lateral sclerosis	0.00288	0.00288	CcSEcCtD
Temozolomide—Feeling abnormal—Riluzole—amyotrophic lateral sclerosis	0.00278	0.00278	CcSEcCtD
Temozolomide—Gastrointestinal pain—Riluzole—amyotrophic lateral sclerosis	0.00276	0.00276	CcSEcCtD
Temozolomide—Urticaria—Riluzole—amyotrophic lateral sclerosis	0.00268	0.00268	CcSEcCtD
Temozolomide—Abdominal pain—Riluzole—amyotrophic lateral sclerosis	0.00266	0.00266	CcSEcCtD
Temozolomide—Body temperature increased—Riluzole—amyotrophic lateral sclerosis	0.00266	0.00266	CcSEcCtD
Temozolomide—Hypersensitivity—Riluzole—amyotrophic lateral sclerosis	0.00248	0.00248	CcSEcCtD
Temozolomide—Asthenia—Riluzole—amyotrophic lateral sclerosis	0.00242	0.00242	CcSEcCtD
Temozolomide—Pruritus—Riluzole—amyotrophic lateral sclerosis	0.00238	0.00238	CcSEcCtD
Temozolomide—Diarrhoea—Riluzole—amyotrophic lateral sclerosis	0.00231	0.00231	CcSEcCtD
Temozolomide—Dizziness—Riluzole—amyotrophic lateral sclerosis	0.00223	0.00223	CcSEcCtD
Temozolomide—Vomiting—Riluzole—amyotrophic lateral sclerosis	0.00214	0.00214	CcSEcCtD
Temozolomide—Rash—Riluzole—amyotrophic lateral sclerosis	0.00213	0.00213	CcSEcCtD
Temozolomide—Dermatitis—Riluzole—amyotrophic lateral sclerosis	0.00212	0.00212	CcSEcCtD
Temozolomide—Headache—Riluzole—amyotrophic lateral sclerosis	0.00211	0.00211	CcSEcCtD
Temozolomide—Nausea—Riluzole—amyotrophic lateral sclerosis	0.002	0.002	CcSEcCtD
